Add to ORKGHyaluronic acid-based nanocomplexes have been synthesized and tested as an innovative therapeutic tool to treat myotonic dystroph
Duchenne muscular dystrophy (DMD) is a severe hereditary neurodegenerative disorder due to mutations...
For subsets of Duchenne muscular dystrophy (DMD) mutations, antisense oligoribonucleotide (AON)-medi...
For subsets of Duchenne muscular dystrophy (DMD) mutations, antisense oligoribonucleotide (AON)-medi...
In a context of drug repurposing, pentamidine (PTM), an FDA-approved antiparasitic drug, has been pr...
In a context of drug repurposing, pentamidine (PTM), an FDA-approved antiparasitic drug, has been pr...
Myotonic dystrophy (DM) represents a genetic disorder characterized by progressive dysfunction of mu...
Hyaluronic acid-based nanocomplexes have been synthesized and tested as an innovative therapeutic to...
Myotonic dystrophies (DMs) are neuromuscular diseases of genetic origin that involve multiple organs...
Hyaluronic acid-based nanocomplexes have been developpend as novel drug-nanocarriers to treat myoton...
Overview of the results obtained so far in the frame of a research on suitable nanocarriers for trea...
Muscular Dystrophies (MDs) are a group of rare inherited genetic muscular pathologies encompassing a...
Muscular dystrophies are a group of genetic muscular diseases characterized by impaired muscle regen...
Muscular Dystrophies (MDs) are a group of rare inherited genetic muscular pathologies encompassing a...
Muscular Dystrophies (MDs) are a group of rare inherited genetic muscular pathologies encompassing a...
Duchenne muscular dystrophy (DMD) is a severe hereditary neurodegenerative disorder due to mutations...
Duchenne muscular dystrophy (DMD) is a severe hereditary neurodegenerative disorder due to mutations...
For subsets of Duchenne muscular dystrophy (DMD) mutations, antisense oligoribonucleotide (AON)-medi...
For subsets of Duchenne muscular dystrophy (DMD) mutations, antisense oligoribonucleotide (AON)-medi...
In a context of drug repurposing, pentamidine (PTM), an FDA-approved antiparasitic drug, has been pr...
In a context of drug repurposing, pentamidine (PTM), an FDA-approved antiparasitic drug, has been pr...
Myotonic dystrophy (DM) represents a genetic disorder characterized by progressive dysfunction of mu...
Hyaluronic acid-based nanocomplexes have been synthesized and tested as an innovative therapeutic to...
Myotonic dystrophies (DMs) are neuromuscular diseases of genetic origin that involve multiple organs...
Hyaluronic acid-based nanocomplexes have been developpend as novel drug-nanocarriers to treat myoton...
Overview of the results obtained so far in the frame of a research on suitable nanocarriers for trea...
Muscular Dystrophies (MDs) are a group of rare inherited genetic muscular pathologies encompassing a...
Muscular dystrophies are a group of genetic muscular diseases characterized by impaired muscle regen...
Muscular Dystrophies (MDs) are a group of rare inherited genetic muscular pathologies encompassing a...
Muscular Dystrophies (MDs) are a group of rare inherited genetic muscular pathologies encompassing a...
Duchenne muscular dystrophy (DMD) is a severe hereditary neurodegenerative disorder due to mutations...
Duchenne muscular dystrophy (DMD) is a severe hereditary neurodegenerative disorder due to mutations...
For subsets of Duchenne muscular dystrophy (DMD) mutations, antisense oligoribonucleotide (AON)-medi...
For subsets of Duchenne muscular dystrophy (DMD) mutations, antisense oligoribonucleotide (AON)-medi...